Français
ItalianoBond Merck & Co 4.3% ( US674599DT91 ) in USD
| Issuer | Merck & Co | ||
| Market price |  % ⇌ |
||
| Country |  United States
|
||
| ISIN code |
 US674599DT91 ( in USD )
|
||
| Interest rate | 4.3% per year ( payment 2 times a year) | ||
| Maturity | 22/05/2028 | ||
|
Prospectus brochure in PDF format |
|||
| Minimal amount | / | ||
| Total amount | / | ||
| Cusip | 674599DT9 | ||
| Standard & Poor's ( S&P ) rating | BB+ ( Non-investment grade speculative ) | ||
| Moody's rating | Baa3 ( Lower medium grade - Investment-grade ) | ||
| Next Coupon | 22/11/2026 ( In 97 days ) | ||
| Detailed description |
Merck & Co., Inc. is a leading global biopharmaceutical company that discovers, develops, manufactures, and markets a broad range of innovative health solutions across various therapeutic areas. The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US674599DT91, pays a coupon of 4.3% per year. The coupons are paid 2 times per year and the Bond maturity is 22/05/2028 The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US674599DT91, was rated Baa3 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Merck & Co ( United States ) , in USD, with the ISIN code US674599DT91, was rated BB+ ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||
| |||